Welcome to our dedicated page for Putnam BioRevolution ETF news (Ticker: SYNB), a resource for investors and traders seeking the latest updates and insights on Putnam BioRevolution ETF stock.
The news page for Putnam BioRevolution ETF (SYNB) focuses on coverage related to the fund and its announced liquidation and dissolution. A Business Wire announcement from Franklin Templeton explains that the Putnam BioRevolution ETF (SYNB) is an exchange-traded fund listed on NYSE Arca and that Franklin Templeton plans to liquidate and dissolve the fund under a defined schedule. News items linked to this symbol often center on that plan and the key dates associated with it.
According to the Franklin Templeton communication, the fund will stop accepting orders for the purchase of creation units as of the close of business on October 24, 2025, and will stop accepting redemption orders as of the close of business on November 13, 2025. The same announcement notes that trading for SYNB on NYSE Arca is expected to be suspended prior to market open on November 14, 2025, with liquidation of remaining assets and cash distributions to shareholders anticipated on or about November 21, 2025.
News related to SYNB may therefore include updates and commentary tied to this liquidation timeline, as well as references to Franklin Templeton and Franklin Resources, Inc., which are described in the announcement as a global investment management organization with subsidiaries operating under the Franklin Templeton name. For readers tracking the history and wind-down of the Putnam BioRevolution ETF, this news page serves as a focused place to review coverage of the fund’s planned closure, associated trading milestones, and communications from Franklin Templeton regarding the process.
Franklin Templeton (NYSE:BEN) has announced the liquidation of its Putnam BioRevolution™ ETF (SYNB). The fund will cease accepting creation unit orders after October 24, 2025, and redemption orders after November 13, 2025.
Trading on NYSE Arca will be suspended before market open on November 14, 2025. The final liquidation is scheduled for November 21, 2025, when remaining shareholders will receive pro rata cash distributions after all fund obligations are met.